Daniel Powell: KRAS Peptide-Centric CAR T Cell Therapy at WIC APAC 2025
Daniel Powell, Professor at University of Pennsylvania, shared Society for Immunotherapy of Cancer (SITC)‘s post on LinkedIn, adding:
“I’m looking forward to highlighting some of our recent work on KRAS peptide-centric CAR T cell therapy (and patient specific neoAg CARs), as well as meeting many of you, at WIC APAC2025 in Singapore.”
Title: Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
Authors: Alexander Benton, Jiageng Liu, Mathilde A. Poussin, Andrea Lang Goldgewicht, Madhara Udawela, Adham S. Bear, Nils Wellhausen, Beatriz M. Carreno, Pete M. Smith, Matthew D. Beasley, Ben R. Kiefel, Daniel J. Powell Jr.
Read the Full Article on Cancer Cell
Quoting Immunotherapy of Cancer (SITC)’s post:
“The Society for Immunotherapy of Cancer (SITC) is proud to join top immuno-oncology organizations from across the Asia-Pacific region for the World Immunotherapy Council Asia-Pacific (WIC-APAC) Conference July 21–22, 2025, in Singapore!
This immersive global collaboration will feature leading immunotherapy experts sharing insights on the latest advancements in immunotherapy, from novel treatments to evolving clinical applications and regulatory updates.
Discover how the next generation of researchers is transforming immunotherapy and explore new opportunities to drive innovation!
Bernard Fox, Co-Founder, President, CEO at UbiVac, shared Daniel Powell’s post, adding:
“Really looking forward to Prof. Daniel Powell ‘s talk on peptide centric CAR!.”
More posts featuring Society for Immunotherapy of Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023